Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours
Name:
mdz244.026.pdf
Size:
87.92Kb
Format:
PDF
Description:
From UNPAYWALL. Conference abstract
Authors
Cook, NatalieBanerji, U
Evans, J
Biondo, A
Germetaki, Theodora
Randhawa, M
Godfrey, L
Leslie, S
Jeffrey, P
Rigby, M
Bennett, G
Blakemore, S
Koehler, M
Niewiarowski, A
Pittman, M
Symeonides, SN
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, ManchesterIssue Date
2019
Metadata
Show full item recordCitation
Cook N, Banerji U, Evans J, Biondo A, Germetaki T, Randhawa M, et al. 464P Pharmacokinetic (PK) assessment of BT1718: A phase I/II a study of BT1718, a first in class bicycle toxin conjugate (BTC), in patients (pts) with advanced solid tumours. Annals of Oncology. 2019;30(Supplement_5):174.Journal
Annals of OncologyDOI
10.1093/annonc/mdz244.026Additional Links
https://dx.doi.org/10.1093/annonc/mdz244.026Type
Meetings and ProceedingsLanguage
enae974a485f413a2113503eed53cd6c53
10.1093/annonc/mdz244.026